Journal of Urologic Oncology

Review Article

Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era? (145 times): Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo; Korean J Urol Oncol. 2022;20(3):139-150. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.139; Full text PubReader ePub PDF

Reivew Article

Complex Epidemiology of Prostate Cancer in Asian Countries (125 times): Kagenori Ito, Takahiro Kimura; Journal of Urologic Oncology. 2023;21(1):5-13. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600140007
Cited By 2; Full text PubReader ePub PDF

Review Article

An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer (147 times): Jeong Hee Hong; Korean J Urol Oncol. 2022;20(4):207-222. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.207
Cited By 2; Full text PubReader ePub PDF

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer

Invited Review

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023 (31 times): Jiwoong Yu, Hyun Hwan Sung; Journal of Urologic Oncology. 2023;21(3):228-240. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600420021
Cited By 1; Full text PubReader ePub PDF

Reivew Article

Current Update on Prostate Cancer Immunotherapy (100 times): Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim; Journal of Urologic Oncology. 2023;21(1):14-22. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600100005; Full text PubReader ePub PDF

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma

Invited Review

Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma (32 times): Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, Mehmet A. Bilen, Kenneth Ogan, Viraj A. Master; Journal of Urologic Oncology. 2023;21(3):183-199. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600500025
Cited By 2; Full text PubReader ePub PDF

Topic Article

Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis (25 times): Jin Noh, Sang Hun Song, Gyoohwan Jung, Sangchul Lee, Sung Kyu Hong, Seok Soo Byun, Jung Kwon Kim; Journal of Urologic Oncology. 2023;21(3):200-207. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600480024
Cited By 1; Full text PubReader ePub PDF

Invited Review

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects (33 times): Hyerim Ha, Joo Han Lim; Journal of Urologic Oncology. 2023;21(3):208-216. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600540027
Cited By 1; Full text PubReader ePub PDF

Review Article

Artificial Intelligence on Urology Lab (103 times): Jae Baek Ha, Jaewoon Jeong, Jeongyoon Suh, Sungyun Park, Ruei Ting Wang, Taewoo Kim, Ji Eun Koh, Jong Hyun Tae, In Ho Chang, Se Young Choi; Korean J Urol Oncol. 2022;20(3):163-176. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.163; Full text PubReader ePub PDF

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer

Original Article

Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy (20 times): Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, Won Hoon Song, Seung Soo Lee, Sung Woo Park, Jong Kil Nam; Journal of Urologic Oncology. 2023;21(3):249-256. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600400020
Cited By 1; Full text PubReader ePub PDF

Review Article

The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer (119 times): Jae Young Joung, Sung Han Kim; Korean J Urol Oncol. 2022;20(1):1-11. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.1
Cited By 1; Full text PubReader ePub PDF

Trimodality Therapy and Immuno-Oncology for Bladder Cancer

Original Article

Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis (44 times): Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, Jongchan Kim, Won Sik Jang, Jee Soo Park, Won Sik Ham; Journal of Urologic Oncology. 2023;21(2):165-173. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600280014
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Original Article

A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association (56 times): Yun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwak; Korean J Urol Oncol. 2022;20(4):265-272. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.265
Cited By 1; Full text PubReader ePub PDF Supplementary Material

mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness

Invited Review

The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance (46 times): Chang Wook Jeong; Journal of Urologic Oncology. 2023;21(2):97-105. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600260013
Cited By 1; Full text PubReader ePub PDF

Review Article

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer (101 times): Jaewoon Jeong, Jae Baek Ha, In Ho Chang; Korean J Urol Oncol. 2022;20(1):12-24. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.12; Full text PubReader ePub PDF

Review Article

Animal Models for Bone Metastatic Prostate Cancer (40 times): Woo Hyeok Jeon, Cheeun Song, Seung Ju Jang, Sejung Maeng, In Ho Chang, Jong Hyun Tae; Korean J Urol Oncol. 2022;20(4):248-256. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.248; Full text PubReader ePub PDF

Original Article

Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database (50 times): Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, Woo Suk Choi, Yun-Sok Ha, Jeong Hyun Kim, Cheol Kwak; Journal of Urologic Oncology. 2023;21(1):45-52. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600040002
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Clinical Predictors of ARTA Response in Metastatic Prostate Cancer

Topic Article

Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer (17 times): Jaeyoung Cho, Jungyo Suh, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Bumjin Lim; Journal of Urologic Oncology. 2023;21(3):257-263. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234604600023
Cited By 1; Full text PubReader ePub PDF

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer

Topic Article

Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer (18 times): Chung Un Lee, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Seong Il Seo, Seong Soo Jeon, Se Hoon Park, Byong Chang Jeong; Journal of Urologic Oncology. 2023;21(3):241-248. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600620031
Cited By 1; Full text PubReader ePub PDF

Prostate Cancer

Invited Review

Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review (15 times): Minseok Suh, Gi Jeong Cheon; Journal of Urologic Oncology. 2024;22(1):11-20. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600200010
Cited By 1; Full text PubReader ePub PDF

4,142	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
3,841	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
3,473	The Present and Future of Intravesical Therapy in Bladder Cancer
3,030	Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study
2,882	Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?

Cited By 4	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 2	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 2	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 2	Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma

Most download articles